緑内障手術用デバイスの市場規模、シェア、動向分析レポート：製品別、手術方法別、最終用途別、セグメント予測、2023年～2030年

緑内障手術用デバイス市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の緑内障手術用デバイス市場は、2023年から2030年にかけてCAGR 4.61％を記録し、2030年には22億7,000万米ドルに達すると予測されています。

緑内障の世界の負担増が予測期間中の市場成長に寄与すると見られています。また、有利な償還政策や外国直接投資条項などの政府支援は、特に新興国市場での市場成長を促進すると予測されます。低侵襲緑内障手術（MIGS）に対する需要の高まりは、予測期間にわたって先進的な緑内障手術用デバイスに対する需要を促進すると予想されます。

政府や非営利団体は、緑内障やその治療に用いられる手術に関する知識を高めるためにいくつかのキャンペーンを開始しています。このような取り組みが、最先端の手術法に対する需要の増加につながると期待されています。加えて、洗練された低侵襲手術法への消費者の嗜好のシフトは、市場拡大にプラスの影響を与えると予想されます。さらに、緑内障の治療において、薬物療法よりも外科的治療の採用率が高いことが、近い将来の市場成長を後押しすると予想されます。外用薬を含む従来の緑内障治療法は、レーザー手術に続く第一選択治療と考えられています。

米国国立医学図書館（NCBI）によると、2018年には緑内障と診断された患者に約4万件のMIGS手術が行われました。この低侵襲手術は入院期間を短縮し、患者が院内感染にかかる可能性を低下させることができます。また、入院期間が短縮されることで、患者はより早く通常の生活に戻ることができます。先進的な機器の頻繁な発売も、予測期間中の市場成長を促進すると予想されます。例えば、2023年4月、ジョンソン・エンド・ジョンソンビジョンは、レーシックフラップ開発用フェムトセカンドレーザー「ELITA」の米国FDA 510（k）認可を取得しました。

緑内障手術用デバイス市場レポートハイライト

• 製品別では、従来の緑内障手術への嗜好が高いことから、従来の手術用デバイスセグメントが2022年に40％以上のシェアを獲得し、市場を独占しました。
• 手術方法に基づくと、従来の緑内障手術セグメントは、その効率性により、2022年に35.11%の最大市場シェアを占めました。
• 眼科クリニックの最終用途セグメントは、眼科およびその他の関連疾患に苦しむ患者数の増加に起因して、予測期間中に最も速いCAGR 4.80％で拡大すると予想されています。
• 北米は2022年に37.26％の最大シェアを占め、予測期間中も健全なCAGRで拡大すると予測されています。
• アジア太平洋は、主要企業の存在と糖尿病有病率の増加により、予測期間中に最も急成長する地域市場になると予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 緑内障手術用デバイス市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 普及と成長の見通しマッピング
• 業界のバリューチェーン分析
  • 償還の枠組み
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 緑内障手術用デバイス市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析
  • 主要取引と戦略的提携の分析
  • 市場参入戦略

第4章 緑内障手術用デバイス市場：製品の推定・動向分析

• 定義と範囲
• 製品の市場シェア、2018年と2030年
• セグメントダッシュボード
• 製品別の世界の緑内障手術用デバイス市場の見通し
• 市場規模、予測および動向分析、2018年から2030年まで

第5章 緑内障手術用デバイス市場：手術方法の推定・動向分析

• 定義と範囲
• 手術方法の市場シェア、2018年と2030年
• セグメントダッシュボード
• 手術方法別の世界の緑内障手術用デバイス市場の見通し
• 市場規模、予測および動向分析、2018年から2030年まで

第6章 緑内障手術用デバイス市場：最終用途の推定・動向分析

• 定義と範囲
• 最終用途の市場シェア、2018年および2030年
• セグメントダッシュボード
• 最終用途別の世界の緑内障手術用デバイス市場の見通し
• 市場規模、予測および動向分析、2018年から2030年まで

第7章 緑内障手術用デバイス市場：地域の推定・動向分析

• 地域の市場シェア分析、2022年および2030年
• 地域の市場ダッシュボード
• 世界の地域市場スナップショット
• 地域の市場シェアと主要企業、2022年
• 市場応用、予測および動向分析、2018年から2030年：
• 北米
  • 市場推計・予測、2018～2030年
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋地域
  • 日本
  • インド
  • 中国
  • 韓国
  • オーストラリア
  • タイ
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 会社/競合の分類
  • イノベーター
• ベンダー情勢
  • List of key distributors and channel partners
  • Key customers
  • Key company market share analysis, 2022
  • Alcon, Inc.
  • Glaukos Corporation
  • Johnson &Johnson Vision
  • AbbVie Inc.（Allergan Plc.）
  • ASICO, LLC
  • Carl Zeiss Meditec AG
  • Katalyst Surgical
  • Lumenis Ltd
  • Ziemer Ophthalmic Systems AG
  • Iridex Corporation
  • Altomed

List of Tables

• Table 1 List of Abbreviation
• Table 2 North America glaucoma surgery devices market, by region, 2018 - 2030 (USD Million)
• Table 3 North America glaucoma surgery devices market, by product, 2018 - 2030 (USD Million)
• Table 4 North America glaucoma surgery devices market, by surgery method, 2018 - 2030 (USD Million)
• Table 5 North America glaucoma surgery devices market, by end use, 2018 - 2030 (USD Million)
• Table 6 U.S. glaucoma surgery devices market, by product, 2018 - 2030 (USD Million)
• Table 7 U.S. glaucoma surgery devices market, by surgery method, 2018 - 2030 (USD Million)
• Table 8 U.S. glaucoma surgery devices market, by end use, 2018 - 2030 (USD Million)
• Table 9 Canada glaucoma surgery devices market, by product, 2018 - 2030 (USD Million)
• Table 10 Canada glaucoma surgery devices market, by surgery method, 2018 - 2030 (USD Million)
• Table 11 Canada glaucoma surgery devices market, by end use, 2018 - 2030 (USD Million)
• Table 12 Europe glaucoma surgery devices market, by region, 2018 - 2030 (USD Million)
• Table 13 Europe glaucoma surgery devices market, by product, 2018 - 2030 (USD Million)
• Table 14 Europe glaucoma surgery devices market, by surgery method, 2018 - 2030 (USD Million)
• Table 15 Europe glaucoma surgery devices market, by end use, 2018 - 2030 (USD Million)
• Table 16 Germany glaucoma surgery devices market, by product, 2018 - 2030 (USD Million)
• Table 17 Germany glaucoma surgery devices market, by surgery method, 2018 - 2030 (USD Million)
• Table 18 Germany glaucoma surgery devices market, by end use, 2018 - 2030 (USD Million)
• Table 19 UK glaucoma surgery devices market, by product, 2018 - 2030 (USD Million)
• Table 20 UK glaucoma surgery devices market, by surgery method, 2018 - 2030 (USD Million)
• Table 21 UK glaucoma surgery devices market, by end use, 2018 - 2030 (USD Million)
• Table 22 France glaucoma surgery devices market, by product, 2018 - 2030 (USD Million)
• Table 23 France glaucoma surgery devices market, by surgery method, 2018 - 2030 (USD Million)
• Table 24 France glaucoma surgery devices market, by end use, 2018 - 2030 (USD Million)
• Table 25 Italy glaucoma surgery devices market, by product, 2018 - 2030 (USD Million)
• Table 26 Italy glaucoma surgery devices market, by surgery method, 2018 - 2030 (USD Million)
• Table 27 Italy glaucoma surgery devices market, by end use, 2018 - 2030 (USD Million)
• Table 28 Spain glaucoma surgery devices market, by product, 2018 - 2030 (USD Million)
• Table 29 Spain glaucoma surgery devices market, by surgery method, 2018 - 2030 (USD Million)
• Table 30 Spain glaucoma surgery devices market, by end use, 2018 - 2030 (USD Million)
• Table 31 Sweden glaucoma surgery devices market, by product, 2018 - 2030 (USD Million)
• Table 32 Sweden glaucoma surgery devices market, by surgery method, 2018 - 2030 (USD Million)
• Table 33 Sweden glaucoma surgery devices market, by end use, 2018 - 2030 (USD Million)
• Table 34 Denmark glaucoma surgery devices market, by product, 2018 - 2030 (USD Million)
• Table 35 Denmark glaucoma surgery devices market, by surgery method, 2018 - 2030 (USD Million)
• Table 36 Denmark glaucoma surgery devices market, by end use, 2018 - 2030 (USD Million)
• Table 37 Norway glaucoma surgery devices market, by product, 2018 - 2030 (USD Million)
• Table 38 Norway glaucoma surgery devices market, by surgery method, 2018 - 2030 (USD Million)
• Table 39 Norway glaucoma surgery devices market, by end use, 2018 - 2030 (USD Million)
• Table 40 Asia Pacific glaucoma surgery devices market, by region, 2018 - 2030 (USD Million)
• Table 41 Asia Pacific glaucoma surgery devices market, by product, 2018 - 2030 (USD Million)
• Table 42 Asia Pacific glaucoma surgery devices market, by surgery method, 2018 - 2030 (USD Million)
• Table 43 Asia Pacific glaucoma surgery devices market, by end use, 2018 - 2030 (USD Million)
• Table 44 China glaucoma surgery devices market, by product, 2018 - 2030 (USD Million)
• Table 45 China glaucoma surgery devices market, by surgery method, 2018 - 2030 (USD Million)
• Table 46 China glaucoma surgery devices market, by end use, 2018 - 2030 (USD Million)
• Table 47 Japan glaucoma surgery devices market, by product, 2018 - 2030 (USD Million)
• Table 48 Japan glaucoma surgery devices market, by surgery method, 2018 - 2030 (USD Million)
• Table 49 Japan glaucoma surgery devices market, by end use, 2018 - 2030 (USD Million)
• Table 50 India glaucoma surgery devices market, by product, 2018 - 2030 (USD Million)
• Table 51 India glaucoma surgery devices market, by surgery method, 2018 - 2030 (USD Million)
• Table 52 India glaucoma surgery devices market, by end use, 2018 - 2030 (USD Million)
• Table 53 Australia glaucoma surgery devices market, by product, 2018 - 2030 (USD Million)
• Table 54 Australia glaucoma surgery devices market, by surgery method, 2018 - 2030 (USD Million)
• Table 55 Australia glaucoma surgery devices market, by end use, 2018 - 2030 (USD Million)
• Table 56 South Korea glaucoma surgery devices market, by product, 2018 - 2030 (USD Million)
• Table 57 South Korea glaucoma surgery devices market, by surgery method, 2018 - 2030 (USD Million)
• Table 58 South Korea glaucoma surgery devices market, by end use, 2018 - 2030 (USD Million)
• Table 59 Thailand glaucoma surgery devices market, by product, 2018 - 2030 (USD Million)
• Table 60 Thailand glaucoma surgery devices market, by surgery method, 2018 - 2030 (USD Million)
• Table 61 Thailand glaucoma surgery devices market, by end use, 2018 - 2030 (USD Million)
• Table 62 Latin America glaucoma surgery devices market, by region, 2018 - 2030 (USD Million)
• Table 63 Latin America glaucoma surgery devices market, by product, 2018 - 2030 (USD Million)
• Table 64 Latin America glaucoma surgery devices market, by surgery method, 2018 - 2030 (USD Million)
• Table 65 Latin America glaucoma surgery devices market, by end use, 2018 - 2030 (USD Million)
• Table 66 Brazil glaucoma surgery devices market, by product, 2018 - 2030 (USD Million)
• Table 67 Brazil glaucoma surgery devices market, by surgery method, 2018 - 2030 (USD Million)
• Table 68 Brazil glaucoma surgery devices market, by end use, 2018 - 2030 (USD Million)
• Table 69 Mexico glaucoma surgery devices market, by product, 2018 - 2030 (USD Million)
• Table 70 Mexico glaucoma surgery devices market, by surgery method, 2018 - 2030 (USD Million)
• Table 71 Mexico glaucoma surgery devices market, by end use, 2018 - 2030 (USD Million)
• Table 72 Argentina glaucoma surgery devices market, by product, 2018 - 2030 (USD Million)
• Table 73 Argentina glaucoma surgery devices market, by surgery method, 2018 - 2030 (USD Million)
• Table 74 Argentina glaucoma surgery devices market, by end use, 2018 - 2030 (USD Million)
• Table 75 Middle East and Africa glaucoma surgery devices market, by region, 2018 - 2030 (USD Million)
• Table 76 Middle East and Africa glaucoma surgery devices market, by product, 2018 - 2030 (USD Million)
• Table 77 Middle East and Africa glaucoma surgery devices market, by surgery method, 2018 - 2030 (USD Million)
• Table 78 Middle East and Africa glaucoma surgery devices market, by end use, 2018 - 2030 (USD Million)
• Table 79 South Africa glaucoma surgery devices market, by product, 2018 - 2030 (USD Million)
• Table 80 South Africa glaucoma surgery devices market, by surgery method, 2018 - 2030 (USD Million)
• Table 81 South Africa glaucoma surgery devices market, by end use, 2018 - 2030 (USD Million)
• Table 82 Saudi Arabia glaucoma surgery devices market, by product, 2018 - 2030 (USD Million)
• Table 83 Saudi Arabia glaucoma surgery devices market, by surgery method, 2018 - 2030 (USD Million)
• Table 84 Saudi Arabia glaucoma surgery devices market, by end use, 2018 - 2030 (USD Million)
• Table 85 UAE glaucoma surgery devices market, by product, 2018 - 2030 (USD Million)
• Table 86 UAE glaucoma surgery devices market, by surgery method, 2018 - 2030 (USD Million)
• Table 87 UAE glaucoma surgery devices market, by end use, 2018 - 2030 (USD Million)
• Table 88 Kuwait glaucoma surgery devices market, by product, 2018 - 2030 (USD Million)
• Table 89 Kuwait glaucoma surgery devices market, by surgery method, 2018 - 2030 (USD Million)
• Table 90 Kuwait glaucoma surgery devices market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Primary interviews in North America
• Fig. 5 Primary interviews in Europe
• Fig. 6 Primary interviews in APAC
• Fig. 7 Primary interviews in Latin America
• Fig. 8 Primary interviews in MEA
• Fig. 9 Market research approaches
• Fig. 10 Value-chain-based sizing & forecasting
• Fig. 11 QFD modeling for market share assessment
• Fig. 12 Market formulation & validation
• Fig. 13 Glaucoma surgery devices market: market outlook
• Fig. 14 Glaucoma surgery devices market competitive insights
• Fig. 15 Parent market outlook
• Fig. 16 Related/ancillary market outlook
• Fig. 17 Penetration and growth prospect mapping
• Fig. 18 Industry value chain analysis
• Fig. 19 Glaucoma surgery devices market driver impact
• Fig. 20 Glaucoma surgery devices market restraint impact
• Fig. 21 Glaucoma surgery devices market strategic initiatives analysis
• Fig. 22 Glaucoma surgery devices market: product movement analysis
• Fig. 23 Glaucoma surgery devices market: product outlook and key takeaways
• Fig. 24 Glaucoma drainage device market estimates and forecast, 2018 - 2030
• Fig. 25 Traditional surgery devices market estimates and forecast, 2018 - 2030
• Fig. 26 Diamond knives market estimates and forecast, 2018 - 2030
• Fig. 27 Laser systems market estimates and forecast, 2018 - 2030
• Fig. 28 Others market estimates and forecast, 2018 - 2030
• Fig. 29 Glaucoma surgery devices market: surgery method movement analysis
• Fig. 30 Glaucoma surgery devices market: surgery method outlook and key takeaways
• Fig. 31 Traditional glaucoma surgery market estimates and forecast, 2018 - 2030
• Fig. 32 Minimal invasive glaucoma surgery market estimates and forecast, 2018 - 2030
• Fig. 33 Laser surgery market estimates and forecast, 2018 - 2030
• Fig. 34 Glaucoma surgery devices market: end use movement analysis
• Fig. 35 Glaucoma surgery devices market: end use outlook and key takeaways
• Fig. 36 Hospitals market estimates and forecast, 2018 - 2030
• Fig. 37 Ophthalmic clinics market estimates and forecast, 2018 - 2030
• Fig. 38 Others market estimates and forecast, 2018 - 2030
• Fig. 39 Global glaucoma surgery devices market: regional movement analysis
• Fig. 40 Global glaucoma surgery devices market: regional outlook and key takeaways
• Fig. 41 Global market shares and leading players
• Fig. 42 North America market share and leading players
• Fig. 43 Europe market share and leading players
• Fig. 44 Asia Pacific market share and leading players
• Fig. 45 Latin America market share and leading players
• Fig. 46 Middle East & Africa market share and leading players
• Fig. 47 North America: SWOT
• Fig. 48 Europe SWOT
• Fig. 49 Asia Pacific SWOT
• Fig. 50 Latin America SWOT
• Fig. 51 MEA SWOT
• Fig. 52 North America, by country
• Fig. 53 North America
• Fig. 54 North America market estimates and forecast, 2018 - 2030
• Fig. 55 U.S.
• Fig. 56 U.S. market estimates and forecast, 2018 - 2030
• Fig. 57 Canada
• Fig. 58 Canada market estimates and forecast, 2018 - 2030
• Fig. 59 Europe
• Fig. 60 Europe. market estimates and forecast, 2018 - 2030
• Fig. 61 UK
• Fig. 62 UK market estimates and forecast, 2018 - 2030
• Fig. 63 Germany
• Fig. 64 Germany market estimates and forecast, 2018 - 2030
• Fig. 65 France
• Fig. 66 France market estimates and forecast, 2018 - 2030
• Fig. 67 Italy
• Fig. 68 Italy market estimates and forecast, 2018 - 2030
• Fig. 69 Spain
• Fig. 70 Spain market estimates and forecast, 2018 - 2030
• Fig. 71 Sweden
• Fig. 72 Sweden market estimates and forecast, 2018 - 2030
• Fig. 73 Denmark
• Fig. 74 Denmark market estimates and forecast, 2018 - 2030
• Fig. 75 Norway
• Fig. 76 Norway market estimates and forecast, 2018 - 2030
• Fig. 77 Asia Pacific
• Fig. 78 Asia Pacific market estimates and forecast, 2018 - 2030
• Fig. 79 China
• Fig. 80 China market estimates and forecast, 2018 - 2030
• Fig. 81 Japan
• Fig. 82 Japan market estimates and forecast, 2018 - 2030
• Fig. 83 India
• Fig. 84 India market estimates and forecast, 2018 - 2030
• Fig. 85 Australia
• Fig. 86 Australia market estimates and forecast, 2018 - 2030
• Fig. 87 South Korea
• Fig. 88 South Korea market estimates and forecast, 2018 - 2030
• Fig. 89 Thailand
• Fig. 90 Thailand market estimates and forecast, 2018 - 2030
• Fig. 91 Latin America
• Fig. 92 Latin America market estimates and forecast, 2018 - 2030
• Fig. 93 Brazil
• Fig. 94 Brazil market estimates and forecast, 2018 - 2030
• Fig. 95 Mexico
• Fig. 96 Mexico market estimates and forecast, 2018 - 2030
• Fig. 97 Argentina
• Fig. 98 Argentina market estimates and forecast, 2018 - 2030
• Fig. 99 Middle East and Africa
• Fig. 100 Middle East and Africa. market estimates and forecast, 2018 - 2030
• Fig. 101 Saudi Arabia
• Fig. 102 Saudi Arabia market estimates and forecast, 2018 - 2030
• Fig. 103 South Africa
• Fig. 104 South Africa market estimates and forecast, 2018 - 2030
• Fig. 105 UAE
• Fig. 106 UAE market estimates and forecast, 2018 - 2030
• Fig. 107 Kuwait
• Fig. 108 Kuwait market estimates and forecast, 2018 - 2030
• Fig. 109 Participant categorization- Glaucoma surgery devices market
• Fig. 110 Market share of key market players- Glaucoma surgery devices market

Glaucoma Surgery Devices Market Growth & Trends:

The global glaucoma surgery devices market is expected to reach USD 2.27 billion by 2030, registering a CAGR of 4.61% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The rising global burden of glaucoma is expected to contribute to market growth over the forecast period. In addition, government support, such as favorable reimbursement policies and foreign direct investment provisions, is expected to drive market growth, especially in developing regions. Rising demand for Minimally Invasive Glaucoma Surgery (MIGS) procedures is expected to drive the demand for advanced glaucoma surgery devices over the forecast period.

The government and non-profit organizations have launched several campaigns to raise knowledge about glaucoma and the procedures used to treat it. These efforts are expected to help increase the demand for cutting-edge surgical methods. In addition, a shift in consumer preference toward sophisticated minimally invasive surgical procedures is anticipated to positively affect market expansion. Moreover, the high adoption of surgical treatment over medications for the treatment of glaucoma is expected to boost the market growth in the near future. The traditional way of glaucoma therapy involving topical medications is considered first-line treatment followed by laser surgery.

The development of new procedures, such as MIGS, creates new growth opportunities in the market.According to the National Library of Medicine (NCBI), approximately 40,000 MIGS surgical procedures were performed in patients diagnosed with glaucoma in 2018. This minimally invasive surgery can reduce hospital stays, lowering the chance of patients contracting hospital-acquired infections. Shorter hospital stays also enable patients to return to their normal lives quicker. Frequent launches of advanced devices are also expected to fuel market growth during the forecast period. For instance, in April 2023, Johnson & Johnson Vision received the U.S. FDA 510 (k) clearance for its ELITA Femtosecond laser for the development of LASIK flaps.

Glaucoma Surgery Devices Market Report Highlights:

• By product, the traditional surgery devices segment dominated the market by capturing a share of over 40% in 2022 owing to the high preference for traditional glaucoma surgery
• Based on surgery method, the traditional glaucoma surgery segment held the largest market share of 35.11% in 2022 owing to its efficiency
• The ophthalmic clinics end-use segment is expected to expand at the fastest CAGR of 4.80% over the forecast period attributed to the rising number of patients suffering from ophthalmic and other related disorders
• North America held the largest share of 37.26% in 2022 and is expected to expand at a healthy CAGR over the forecast period
• Asia Pacific is expected to be the fastest-growing regional market over the forecast period due to the presence of key players and the increasing prevalence of diabetes

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. Surgery Method
  • 1.1.3. End-use
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for Primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Surgery Method outlook
  • 2.2.3. End-use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Glaucoma Surgery Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Industry Value Chain Analysis
  • 3.3.1. Reimbursement framework
• 3.4. Market Dynamics
  • 3.4.1. Market driver analysis
    • 3.4.1.1. Rising geriatric population
    • 3.4.1.2. Growing adoption of surgical treatments for glaucoma
    • 3.4.1.3. Rising number of government and non-government glaucoma care initiatives
    • 3.4.1.4. Growing prevalence of diabetes
  • 3.4.2. Market restraint analysis
    • 3.4.2.1. Availability of alternative treatment methods
    • 3.4.2.2. Lack of awareness about glaucoma and its treatment procedures in underdeveloped countries
• 3.5. Glaucoma Surgery Devices Market Analysis Tools
  • 3.5.1. Industry Analysis - Porter's
    • 3.5.1.1. Supplier power
    • 3.5.1.2. Buyer power
    • 3.5.1.3. Substitution threat
    • 3.5.1.4. Threat of new entrant
    • 3.5.1.5. Competitive rivalry
  • 3.5.2. PESTEL Analysis
    • 3.5.2.1. Political landscape
    • 3.5.2.2. Technological landscape
    • 3.5.2.3. Economic landscape
  • 3.5.3. Major Deals & Strategic Alliances Analysis
  • 3.5.4. Market Entry Strategies

Chapter 4. Glaucoma Surgery Devices Market: Product Estimates & Trend Analysis

• 4.1. Definitions and Scope
  • 4.1.1. Glaucoma Drainage Devices
    • 4.1.1.1. Valves
    • 4.1.1.2. Glaucoma Drainage Implant
    • 4.1.1.3. Glaucoma Tube Shunts
    • 4.1.1.4. Stents
  • 4.1.2. Traditional Surgery Devices
    • 4.1.2.1. Scalpel
    • 4.1.2.2. Forceps
    • 4.1.2.3. Ophthalmic Scissors
    • 4.1.2.4. Punch
    • 4.1.2.5. Sutures
    • 4.1.2.6. Surgical Drapes
    • 4.1.2.7. Microcatheter
    • 4.1.2.8. Others
  • 4.1.3. Diamond Knives
  • 4.1.4. Laser Systems
  • 4.1.5. Others
• 4.2. Product Market Share, 2018 & 2030
• 4.3. Segment Dashboard
• 4.4. Global Glaucoma Surgery Devices Market by Product Outlook
• 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5.1. Glaucoma Drainage Devices
    • 4.5.1.1. Glaucoma drainage devices market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.1.2. Valves
    • 4.5.1.2.1. Valves market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.1.3. Glaucoma Drainage Implant
    • 4.5.1.3.1. Glaucoma draingae implant market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.1.4. Glaucoma Tube Shunts
    • 4.5.1.4.1. Glaucoma tube shunts market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.1.5. Stents
    • 4.5.1.5.1. Stents market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.2. Traditional Surgery Devices
    • 4.5.2.1. Traditional surgery devices market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.2. Scalpel
    • 4.5.2.2.1. Scalpel market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.3. Forceps
    • 4.5.2.3.1. Forceps market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.4. Ophthalmic Scissors
    • 4.5.2.4.1. Ophthalmic scissors market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.5. Punch
    • 4.5.2.5.1. Punch market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.6. Sutures
    • 4.5.2.6.1. Sutures market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.7. Surgical Drapes
    • 4.5.2.7.1. Surgical drapes market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.8. Microcatheter
    • 4.5.2.8.1. Microcatheter market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.9. Others
    • 4.5.2.9.1. Others market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.3. Diamond Knives
    • 4.5.3.1. Diamond knives market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.4. Laser Systems
    • 4.5.4.1. Laser systems market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.5. Others
    • 4.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Glaucoma Surgery Devices Market: Surgery Method Estimates & Trend Analysis

• 5.1. Definitions and Scope
  • 5.1.1. Traditional Glaucoma Surgery
  • 5.1.2. Minimally Invasive Glaucoma Surgery
  • 5.1.3. Laser Surgery
• 5.2. Surgery Method Market Share, 2018 & 2030
• 5.3. Segment Dashboard
• 5.4. Global Glaucoma Surgery Devices Market by Surgery Method Outlook
• 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5.1. Traditional Glaucoma Surgery
    • 5.5.1.1. Traditional glaucoma surgery market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.1.2. Trabeculectomy
    • 5.5.1.2.1. Trabeculectomy market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.1.3. Tube Shunt Surgery
    • 5.5.1.3.1. Tube shunt surgery market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.2. Minimally Invasive Glaucoma Surgery
    • 5.5.2.1. Minimally invasive glaucoma surgery market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2.2. Trabecular Meshwork Bypass
    • 5.5.2.2.1. Trabecular meshwork bypass market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2.3. Suprachoroidal Space Implants
    • 5.5.2.3.1. Suprachoroidal space implants market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2.4. Subconjunctival Space Implants
    • 5.5.2.4.1. Subconjunctival space implants market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2.5. Schlemm's Canal Implants
    • 5.5.2.5.1. Schlemm's canal implants market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2.6. Gonioscopy-assisted Transluminal Trabeculectomy
    • 5.5.2.6.1. Gonioscopy-assisted transluminal trabeculectomy market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2.7. Endocyclophotocoagulation
    • 5.5.2.7.1. Endocyclophotocoagulation market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.3. Laser Surgery
    • 5.5.3.1. Laser surgery market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.3.2. Trabeculoplasty
    • 5.5.3.2.1. Trabeculoplasty market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.3.3. Iridotomy
    • 5.5.3.3.1. Iridotomy market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.3.4. Cyclophotocoagulation
    • 5.5.3.4.1. Cyclophotocoagulation market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Glaucoma Surgery Devices Market: End-use Estimates & Trend Analysis

• 6.1. Definitions and Scope
  • 6.1.1. Hospitals
  • 6.1.2. Ophthalmic Clinics
  • 6.1.3. Others
• 6.2. End-use Market Share, 2018 & 2030
• 6.3. Segment Dashboard
• 6.4. Global Glaucoma Surgery Devices Market by End-use Outlook
• 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5.1. Hospitals
    • 6.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.2. Ophthalmic Clinics
    • 6.5.2.1. Ophthalmic Clinics market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.3. Others
    • 6.5.3.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Glaucoma Surgery Devices Market: Regional Estimates & Trend Analysis

• 7.1. Regional market share analysis, 2022 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. Regional Market Share and Leading Players, 2022
  • 7.4.1. North America
  • 7.4.2. Europe
  • 7.4.3. Asia Pacific
  • 7.4.4. Latin America
  • 7.4.5. Middle East and Africa
• 7.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030:
• 7.6. North America
  • 7.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 7.6.2. U.S.
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. U.S. market estimates and forecasts, 2018 - 2030
  • 7.6.3. Canada
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. Canada market estimates and forecasts, 2018 - 2030
• 7.7. Europe
  • 7.7.1. UK
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Competitive Scenario
    • 7.7.1.3. Regulatory framework
    • 7.7.1.4. Reimbursement scenario
    • 7.7.1.5. UK market estimates and forecasts, 2018 - 2030
  • 7.7.2. Germany
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. Germany market estimates and forecasts, 2018 - 2030
  • 7.7.3. France
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. France market estimates and forecasts, 2018 - 2030
  • 7.7.4. Italy
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Competitive Scenario
    • 7.7.4.3. Regulatory framework
    • 7.7.4.4. Reimbursement scenario
    • 7.7.4.5. Italy market estimates and forecasts, 2018 - 2030
  • 7.7.5. Spain
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Competitive Scenario
    • 7.7.5.3. Regulatory framework
    • 7.7.5.4. Reimbursement scenario
    • 7.7.5.5. Spain market estimates and forecasts, 2018 - 2030
  • 7.7.6. Denmark
    • 7.7.6.1. Key country dynamics
    • 7.7.6.2. Competitive Scenario
    • 7.7.6.3. Regulatory framework
    • 7.7.6.4. Reimbursement scenario
    • 7.7.6.5. Denmark market estimates and forecasts, 2018 - 2030
  • 7.7.7. Sweden
    • 7.7.7.1. Key country dynamics
    • 7.7.7.2. Competitive Scenario
    • 7.7.7.3. Regulatory framework
    • 7.7.7.4. Reimbursement scenario
    • 7.7.7.5. Sweden market estimates and forecasts, 2018 - 2030
  • 7.7.8. Norway
    • 7.7.8.1. Key country dynamics
    • 7.7.8.2. Competitive Scenario
    • 7.7.8.3. Regulatory framework
    • 7.7.8.4. Reimbursement scenario
    • 7.7.8.5. Norway market estimates and forecasts, 2018 - 2030
• 7.8. Asia Pacific
  • 7.8.1. Japan
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Competitive Scenario
    • 7.8.1.3. Regulatory framework
    • 7.8.1.4. Reimbursement scenario
    • 7.8.1.5. Japan market estimates and forecasts, 2018 - 2030
  • 7.8.2. India
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Competitive Scenario
    • 7.8.2.3. Regulatory framework
    • 7.8.2.4. Reimbursement scenario
    • 7.8.2.5. India market estimates and forecasts, 2018 - 2030
  • 7.8.3. China
    • 7.8.3.1. Key country dynamics
    • 7.8.3.2. Competitive Scenario
    • 7.8.3.3. Regulatory framework
    • 7.8.3.4. Reimbursement scenario
    • 7.8.3.5. China market estimates and forecasts, 2018 - 2030
  • 7.8.4. South Korea
    • 7.8.4.1. Key country dynamics
    • 7.8.4.2. Competitive Scenario
    • 7.8.4.3. Regulatory framework
    • 7.8.4.4. Reimbursement scenario
    • 7.8.4.5. South Korea market estimates and forecasts, 2018 - 2030
  • 7.8.5. Australia
    • 7.8.5.1. Key country dynamics
    • 7.8.5.2. Competitive Scenario
    • 7.8.5.3. Regulatory framework
    • 7.8.5.4. Reimbursement scenario
    • 7.8.5.5. Australia market estimates and forecasts, 2018 - 2030
  • 7.8.6. Thailand
    • 7.8.6.1. Key country dynamics
    • 7.8.6.2. Competitive Scenario
    • 7.8.6.3. Regulatory framework
    • 7.8.6.4. Reimbursement scenario
    • 7.8.6.5. Thailand market estimates and forecasts, 2018 - 2030
• 7.9. Latin America
  • 7.9.1. Brazil
    • 7.9.1.1. Key country dynamics
    • 7.9.1.2. Competitive Scenario
    • 7.9.1.3. Regulatory framework
    • 7.9.1.4. Reimbursement scenario
    • 7.9.1.5. Brazil market estimates and forecasts, 2018 - 2030
  • 7.9.2. Mexico
    • 7.9.2.1. Key country dynamics
    • 7.9.2.2. Competitive Scenario
    • 7.9.2.3. Regulatory framework
    • 7.9.2.4. Reimbursement scenario
    • 7.9.2.5. Mexico market estimates and forecasts, 2018 - 2030
  • 7.9.3. Argentina
    • 7.9.3.1. Key country dynamics
    • 7.9.3.2. Competitive Scenario
    • 7.9.3.3. Regulatory framework
    • 7.9.3.4. Reimbursement scenario
    • 7.9.3.5. Argentina market estimates and forecasts, 2018 - 2030
• 7.10. MEA
  • 7.10.1. South Africa
    • 7.10.1.1. Key country dynamics
    • 7.10.1.2. Competitive Scenario
    • 7.10.1.3. Regulatory framework
    • 7.10.1.4. Reimbursement scenario
    • 7.10.1.5. South Africa market estimates and forecasts, 2018 - 2030
  • 7.10.2. Saudi Arabia
    • 7.10.2.1. Key country dynamics
    • 7.10.2.2. Competitive Scenario
    • 7.10.2.3. Regulatory framework
    • 7.10.2.4. Reimbursement scenario
    • 7.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
  • 7.10.3. UAE
    • 7.10.3.1. Key country dynamics
    • 7.10.3.2. Competitive Scenario
    • 7.10.3.3. Regulatory framework
    • 7.10.3.4. Reimbursement scenario
    • 7.10.3.5. UAE market estimates and forecasts, 2018 - 2030
  • 7.10.4. Kuwait
    • 7.10.4.1. Key country dynamics
    • 7.10.4.2. Competitive Scenario
    • 7.10.4.3. Regulatory framework
    • 7.10.4.4. Reimbursement scenario
    • 7.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
  • 8.2.1. Innovators
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. Key company market share analysis, 2022
  • 8.3.4. Alcon, Inc.
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Glaukos Corporation
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Johnson & Johnson Vision
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. AbbVie Inc. (Allergan Plc.)
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. ASICO, LLC
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Carl Zeiss Meditec AG
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Katalyst Surgical
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. Lumenis Ltd
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. Ziemer Ophthalmic Systems AG
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives
  • 8.3.13. Iridex Corporation
    • 8.3.13.1. Company overview
    • 8.3.13.2. Financial performance
    • 8.3.13.3. Product benchmarking
    • 8.3.13.4. Strategic initiatives
  • 8.3.14. Altomed
    • 8.3.14.1. Company overview
    • 8.3.14.2. Financial performance
    • 8.3.14.3. Product benchmarking
    • 8.3.14.4. Strategic initiatives